Published: 1 October 2025
Lumasiran (Oxlumo) has been listed on the PBS schedule from 1 October 2025.
Due to the medicine’s high cost, claims for lumasiran will be paid in 2 payments to PBS approved suppliers.
The first payment will be made through PBS Online, with the second payment a manual bulk adjustment for the balance.
Claims for lumasiran will be monitored. PBS approved suppliers will get both payments within their usual payment timeframes.
This information was printed 2 October 2025 from https://www.servicesaustralia.gov.au/new-medicine-added-to-pharmaceutical-benefits-scheme-pbs. It may not include all of the relevant information on this topic. Please consider any relevant site notices at https://www.servicesaustralia.gov.au/site-notices when using this material.